Spiriva Handihaler/Spiriva Respimat Dosage/Direction for Use

Spiriva Handihaler: The recommended dosage of SPIRIVA is inhalation of the contents of one capsule once daily with the HandiHaler inhalation device at the same time of day (see Instructions for Use under Cautions for Usage).
Special population: Elderly patients can use SPIRIVA at the recommended dose.
Renally impaired patients can use SPIRIVA at the recommended dose. However, as with all predominantly renally excreted drugs, SPIRIVA use should be monitored closely in patients with moderate to severe renal impairment.
Hepatically impaired patients can use SPIRIVA at the recommended dose.
Paediatric population: There is no experience with SPIRIVA in infants and children and therefore should not be used in this age group.
Spiriva Respimat: The recommended dosage of SPIRIVA RESPIMAT is inhalation of the spray of two puffs once daily from the RESPIMAT inhaler at the same time of day (see Instructions for Use under Cautions for Usage).
In the treatment of asthma, the full benefits will be apparent after several doses of SPIRIVA RESPIMAT.
Special populations: Elderly patients can use SPIRIVA RESPIMAT at the recommended dose.
Renally impaired patients can use SPIRIVA RESPIMAT at the recommended dose. However, as with all predominantly renally excreted drugs, SPIRIVA RESPIMAT use should be monitored closely in patients with moderate to severe renal impairment.
Hepatically impaired patients can use SPIRIVA RESPIMAT at the recommended dose.
Paediatric population: COPD does not normally occur in children.
In asthma, the recommended dosage of SPIRIVA RESPIMAT in patients 6 to 17 years of age is inhalation of the spray of two puffs once daily from the RESPIMAT inhaler, at the same time of day (see Instructions for Use under Cautions for Usage).
The efficacy and safety of SPIRIVA RESPIMAT in paediatric patients below 6 year of age with asthma has not yet been established.
Method of Administration: Spiriva Handihaler: SPIRIVA capsules must not be swallowed.